Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

Go back to Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
Quest Diagnostics (NYSE: DGX) Delayed: 195.00 -2.76 (1.4%)
Previous Close $197.76    52 Week High $86.85 
Open $196.69    52 Week Low $59.66 
Day High $197.44    P/E 36.72 
Day Low $192.83    EPS $5.31 
Volume 1,292,237